Experimental peptide that affects bacterial biofilm stress responses
Preclinical research
Read the profile Peptide profile
LL-37
Also known as Cathelicidin LL-37
Human cathelicidin peptide with antimicrobial and immune-signaling activity
Clinical research
Science, with its context intact.What to knowThe evidence
The evidence
in perspective.
A phase 2b trial studied a topical formulation in venous leg ulcers. This does not establish systemic infection treatment or injectable wellness use.
View the supporting source- Research area
- Immune
- Biological target or mechanism
- Human cathelicidin peptide with antimicrobial and immune-signaling activity
- Evidence context
- Clinical research
- Availability
- Availability requires pharmacy review
From information to a conversationClinical decisions stay
Clinical decisions stay
with clinical professionals.
This profile is a research reference. Your prescriber and pharmacy assess the relevant clinical and dispensing pathway. Inclusion here is not an offer to sell this compound.
